SCHEMBL6809479

SCHEMBL6809479

COc1ccc(-c2sc3cccc(C#N)c3c2N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
APP P05067 2/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ATM Q13315 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ADORA1 P30542 2/20 0.40
ADORA2A P29274 1/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
PTPN1 P18031 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6811980 0.83 APP (0.45) APPMEN1KMT2AATML3MBTL1
SCHEMBL8143138 0.74 KDM4E (0.57) GAAMEN1KMT2AATML3MBTL1
SCHEMBL7689092 0.74 POLB (0.49) POLBGAAMEN1KMT2AADORA1
SCHEMBL6808979 0.74 ATM (0.59) GAAMEN1KMT2AATML3MBTL1
SCHEMBL316475 0.70 KDM4E (0.56) POLBGAAAPPMEN1KMT2A
SCHEMBL16690782 0.70 APP (0.50) GAAAPPMEN1KMT2AL3MBTL1
SCHEMBL6812421 0.68 TUBB4A (0.57) APPMEN1KMT2AATML3MBTL1
SCHEMBL6951995 0.66 ESR2 (0.59) POLBGAAMEN1KMT2AALDH1A1
SCHEMBL21896646 0.66 MAP2K1 (0.41) GAAMEN1KMT2AALDH1A1KDM4E
SCHEMBL8158192 0.65 TUBB4A (0.53) MEN1KMT2AATML3MBTL1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040044224-A1 Process for preparing 2-phenyl-3-aminobenzothiophenes CONRAD PRESTON CHARLES (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044224-A1 Process for preparing 2-phenyl-3-aminobenzothiophenes TPST2, SULT1A1, TYR POLB 529/4885GAA 1634/4885APP 441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.